Documentation

1 - 2

Corporate 2011 Sustainable Development and Activity report
Corporate Roquette Group Communication Kit
Corporate 2010 Sustainable Development Report
Pharma and Personnal Care FORMULATING WITH ROQUETTE EXCIPIENTS / Product guide – 26 pages

For each pharma applications, the guide allows you to choose different products by functionality, and by conformity to the main pharmacopeias.

 

View our brochure on line

 

Corporate Publication of the second sustainable development report for Roquette
Pharma and Personnal Care KLEPTOSE® CRYSMEB exp – Methyl Beta-cyclodextrin from Roquette - 14 pages

CRYSMEB is a unique low methylated derivative of betacyclodextrin. The degree of methylation is controlled in such a manner that the derivative has an advantageous profile of solubilising power and biological tolerance.
 

CRYSMEB could be an alternative solution for cyclodextrin-drug formulations.

Pharma and Personnal Care LYCASIN® 80/55 sugarless excipient for medicinal preparations – 22 pages

A technical brochure incorporating a general introduction to this type of excipient, with detailed information on the physical, chemical and microbiological characteristics of LYCASIN® 80/55. Its biological properties and examples of pharmaceutical applications are also included.

 

View our brochure on line

 

1 - 2